Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicis Undeterred By Inamed’s Breast Implant Panel Woes

This article was originally published in The Gray Sheet

Executive Summary

Medicis has no immediate plans to revisit the financial details of its pending acquisition of Inamed, despite last week's negative FDA panel decision on the latter company's silicone breast implants

You may also be interested in...



Mentor Silicone Implant Panel Sobered By Approval Caveats

Mentor's Memory Gel silicone gel-filled breast implants are reasonably safe for a device lifetime of 10-15 years, according to members of FDA's General & Plastic Surgery Devices Panel

Inamed To Carry On Quest For Silicone Implant Approval After Panel Rejection

Inamed's 20% rupture rate for reconstruction breast implants would drop with the removal of the Style 153 double-lumen implants, according to members of FDA's General & Plastic Surgery Devices Panel

US FDA Pharmaceutical Quality Office Lauds Continuous Manufacturing Approvals

The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.

UsernamePublicRestriction

Register

MT021988

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel